Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Rodrigo Paredes de la Fuente

6PUBLICATIONS
13CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Feb 20, 2026
Evolving Trends in Latin American Participation in Global Oncology Clinical Trials: A Decade of Phase III Activity (2013-2022).

Rodrigo Paredes de la Fuente, Alexander B Karol, Anneliese Markus

|Sep 26, 2025
Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trials.

Alexander B Karol, Rodrigo Paredes, Anna Argulian

|Aug 05, 2025
Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of <i>KEAP1</i>, <i>SMARCA4</i>, and <i>PTEN</i> mutations.

Rodrigo Paredes, Roberto Borea, Francesco Drago

|Jul 10, 2025
Prognostic Role of <i>MTAP</i> Loss in Cholangiocarcinoma.

James Lyon, Soravis Osataphan, Vaibhav Birda

|Aug 10, 2024
Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel.

Rodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce

|Feb 06, 2023
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab.

Rodrigo Paredes de la Fuente, James W Doolin, Mary Linton Peters

Pageof 1

Frequent Collaborators

3 joint publications

Mary Linton Peters

2 joint publications

Alexander B Karol

2 joint publications

Himanshu Joshi

2 joint publications

Yu Fujiwara

2 joint publications

Deborah B Doroshow

1 joint publications

James Lyon

1 joint publications

Soravis Osataphan

1 joint publications

Brian Russell

1 joint publications

Ahmed Rattani

1 joint publications

Lexi Weintraub

Frequent Collaborators

3 joint publications

Mary Linton Peters

2 joint publications

Alexander B Karol

2 joint publications

Himanshu Joshi

2 joint publications

Yu Fujiwara

Top Related Videos

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on : Apr 18, 2025

1.1K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on : Jan 13, 2023

2.3K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.1K
See more related videos

Top Related Videos

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on : Apr 18, 2025

1.1K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on : Jan 13, 2023

2.3K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.1K
See more related videos